These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12322834)

  • 1. Intraperitoneal ondansetron hydrochloride for intractable nausea and vomiting due to diabetic gastroparesis in a patient on peritoneal dialysis.
    Amin K; Bastani B
    Perit Dial Int; 2002; 22(4):539-40. PubMed ID: 12322834
    [No Abstract]   [Full Text] [Related]  

  • 2. Current treatment of nausea and vomiting associated with gastroparesis: antiemetics, prokinetics, tricyclics.
    Stapleton J; Wo JM
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):57-72, vi. PubMed ID: 19232281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroparesis-associated refractory nausea treated with aprepitant.
    Fahler J; Wall GC; Leman BI
    Ann Pharmacother; 2012 Dec; 46(12):e38. PubMed ID: 23191934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Olanzapine Combined with Ondansetron in Prevention of Chemotherapy-Induced Nausea and Vomiting of Non-small Cell Lung Cancer.
    Wang X; Wang L; Wang H; Zhang H
    Cell Biochem Biophys; 2015 Jun; 72(2):471-3. PubMed ID: 25567657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ondansetron with metoclopramide in the symptomatic relief of uremia-induced nausea and vomiting.
    Ljutić D; Perković D; Rumboldt Z; Bagatin J; Hozo I; Pivac N
    Kidney Blood Press Res; 2002; 25(1):61-4. PubMed ID: 11834879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palonosetron compared with ondansetron in pediatric cancer patients: multicycle analysis of a randomized Phase III study.
    Kovács G; Wachtel A; Basharova E; Spinelli T; Nicolas P; Kabickova E
    Future Oncol; 2017 Aug; 13(19):1685-1698. PubMed ID: 28569078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ondansetron is safe and effective for prehospital treatment of nausea and vomiting by paramedics.
    Salvucci AA; Squire B; Burdick M; Luoto M; Brazzel D; Vaezazizi R
    Prehosp Emerg Care; 2011; 15(1):34-8. PubMed ID: 21091329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
    Goldsmith B
    Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626
    [No Abstract]   [Full Text] [Related]  

  • 9. Symptomatic management for gastroparesis: antiemetics, analgesics, and symptom modulators.
    Hasler WL
    Gastroenterol Clin North Am; 2015 Mar; 44(1):113-26. PubMed ID: 25667027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granisetron transdermal system improves refractory nausea and vomiting in gastroparesis.
    Simmons K; Parkman HP
    Dig Dis Sci; 2014 Jun; 59(6):1231-4. PubMed ID: 24615549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaling isopropyl alcohol from alcohol wipes was amore effective antiemetic than oral ondansetron in nauseated adults.
    Dalrymple RA
    Arch Dis Child Educ Pract Ed; 2020 Jun; 105(3):190-191. PubMed ID: 30877088
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of ondansetron in the treatment of nausea and vomiting associated with acetaminophen poisoning.
    Clark RF; Chen R; Williams SR; Johnson CL; Harchelroad F
    J Toxicol Clin Toxicol; 1996; 34(2):163-7. PubMed ID: 8618249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenteral ondansetron for the treatment of chemotherapy- and radiation-induced nausea and vomiting.
    Burnette PK; Perkins J
    Pharmacotherapy; 1992; 12(2):120-31. PubMed ID: 1533280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron.
    Thavaraj V; Arya LS
    Indian Pediatr; 1995 Aug; 32(8):898-901. PubMed ID: 8635834
    [No Abstract]   [Full Text] [Related]  

  • 15. Pre-emptive metoclopramide and ondansetron for nausea and vomiting associated with iloprost infusions.
    Roome C; Thompson J
    Pharm World Sci; 2001 Jun; 23(3):122. PubMed ID: 11468879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ondansetron in the treatment of intractable nausea associated with theophylline toxicity.
    Sage TA; Jones WN; Clark RF
    Ann Pharmacother; 1993 May; 27(5):584-5. PubMed ID: 8347909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful management of intractable nausea with ondansetron: a case study.
    Pereira J; Bruera E
    J Palliat Care; 1996; 12(2):47-50. PubMed ID: 8708852
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
    Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
    Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ondansetron versus metoclopramide in the treatment of postoperative nausea and vomiting.
    Polati E; Verlato G; Finco G; Mosaner W; Grosso S; Gottin L; Pinaroli AM; Ischia S
    Anesth Analg; 1997 Aug; 85(2):395-9. PubMed ID: 9249120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug treatment of adults with nausea and vomiting in primary care.
    Furyk JS; Meek R; McKenzie S
    BMJ; 2014 Aug; 349():g4714. PubMed ID: 25103458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.